Adjustments to Financial Statements
Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
- Income Statement
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Price to Earnings (P/E) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Adjustments to Current Assets
Thermo Fisher Scientific Inc., adjusted current assets
US$ in millions
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Current assets | ||||||
| Adjustments | ||||||
| Add: Allowances | ||||||
| Add: LIFO reserve1 | ||||||
| After Adjustment | ||||||
| Adjusted current assets | ||||||
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 LIFO reserve. See details »
Adjustments to Total Assets
Thermo Fisher Scientific Inc., adjusted total assets
US$ in millions
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »
2 LIFO reserve. See details »
3 Deferred tax assets. See details »
Adjustments to Current Liabilities
Thermo Fisher Scientific Inc., adjusted current liabilities
US$ in millions
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Current liabilities | ||||||
| Adjustments | ||||||
| Less: Current accrued restructuring costs | ||||||
| After Adjustment | ||||||
| Adjusted current liabilities | ||||||
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Adjustments to Total Liabilities
Thermo Fisher Scientific Inc., adjusted total liabilities
US$ in millions
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Deferred tax liabilities. See details »
Adjustments to Stockholders’ Equity
Thermo Fisher Scientific Inc., adjusted total Thermo Fisher Scientific Inc. shareholders’ equity
US$ in millions
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Deferred tax assets (liabilities), net. See details »
2 LIFO reserve. See details »
Adjustments to Capitalization Table
Thermo Fisher Scientific Inc., adjusted capitalization table
US$ in millions
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Operating lease liabilities, current (included in Other accrued expenses). See details »
3 Operating lease liabilities, noncurrent (included in Other long-term liabilities). See details »
4 Deferred tax assets (liabilities), net. See details »
5 LIFO reserve. See details »
Adjustments to Reported Income
Thermo Fisher Scientific Inc., adjusted net income attributable to Thermo Fisher Scientific Inc.
US$ in millions
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Deferred income tax expense (benefit). See details »
2 Increase (decrease) in LIFO reserve. See details »